Literature DB >> 8749567

Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA.

M C Hochberg1, D L Perlmutter, T A Medsger, V Steen, M H Weisman, B White, F M Wigley.   

Abstract

The objective of this study was to estimate the prevalence of self-reported physician-diagnosed systemic lupus erythematosus (SLE) in the USA. During the conduct of an epidemiologic study of systemic sclerosis (scleroderma), 16 607 randomly selected telephone numbers in the continental USA were called to recruit controls. All potentially eligible women were asked 'Have you ever been told by a doctor that you have lupus or SLE'? Of 4034 women aged 18 and above who completed telephone screening, 15 stated they had a physician diagnosis of SLE, corresponding to a prevalence of 372 cases per 100 000 (95% confidence intervals: 208, 614). After review of available medical records in six cases, however, the prevalence of 'validated' SLE was revised to 124 cases per 100 000 (95% confidence intervals: 40, 289). In conclusion, these data suggest that the prevalence of SLE in the USA may be up to three to 10-fold greater than previously estimated. Based on 1990 census data, we would project that over 275 000 women aged 18 and above have SLE in the USA.

Entities:  

Mesh:

Year:  1995        PMID: 8749567     DOI: 10.1177/096120339500400606

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

2.  Connective tissue diseases: Correlating genotypes with disease phenotypes in SLE.

Authors:  Edward K Wakeland
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

Review 3.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

4.  Prevalence and incidence of systemic lupus erythematosus in South Korea.

Authors:  Jee-Seon Shim; Yoon-Kyoung Sung; Young Bin Joo; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

5.  Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico.

Authors:  María J Molina; Angel M Mayor; Alejandro E Franco; Carlos A Morell; Miguel A López; Luis M Vilá
Journal:  J Clin Rheumatol       Date:  2007-08       Impact factor: 3.517

6.  Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection.

Authors:  M D Parkins; D B Gregson; J D D Pitout; T Ross; K B Laupland
Journal:  Infection       Date:  2009-12-12       Impact factor: 3.553

Review 7.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

8.  Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province.

Authors:  Yan-Feng Zou; Chen-Chen Feng; Ji-Min Zhu; Jin-Hui Tao; Gui-Mei Chen; Qian-Ling Ye; Han Cen; Rui-Xue Leng; Fa-Ming Pan; Hai-Feng Pan; Rui Li; Yin-Guang Fan; Bin Wang; Xiang-Pei Li; Feng-Yu Zhang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-11-22       Impact factor: 2.631

9.  Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative.

Authors:  Brian T Walitt; Florina Constantinescu; James D Katz; Arthur Weinstein; Hong Wang; Rohini K Hernandez; Judith Hsia; Barbara V Howard
Journal:  J Rheumatol       Date:  2008-04-01       Impact factor: 4.666

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.